Intermittent Theta Burst Stimulation (iTBS) for Depression
This trial will investigate how stimulating specific brain networks with rTMS changes network connectivity and behavior, in order to establish more effective, individualized treatments for depression.
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Who is able to participate in this medical experiment?
"This clinical trial seeks to enrol 80 adults, aged 18 - 65 years old, who are suffering from major depressive disorder (MDD). Furthermore, applicants must be able to provide informed consent and they may have comorbid anxiety or personality disorders as long MDD is the primary diagnosis."
Does this medical research encompass individuals older than eighty years of age?
"This clinical trial is looking for individuals between 18 and 65 years old to take part."
Are there any enrollment opportunities currently available for this experiment?
"According to clinicaltrials.gov, the trial in question is not presently open for recruitment; this research was initially made available on January 2nd 2023 and last updated August 30th 2022. Despite that, 826 additional studies are still actively recruiting participants at this time."